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Background:  Diagnostic examinations for the evaluation of acute chest pain (ACP) in our emergency department (ED) include CT angiograms 
of the pulmonary arteries, CT aortograms, and CT angiograms of the coronary arteries. However, a single negative study can lead to additional 
(downsteam) radiologic examinations that increase radiation dose. Modified from our coronary CTA study, our “triple rule out” protocol evaluates 
not only the coronary arteries, but also the pulmonary arteries and thoracic aorta. We compared the radiation dose to the patient population who 
underwent a traditional CTA study to those who underwent a“triple rule out” study.
Methods: Two subject groups were retrospectively selected between July 2009 to December 2009
1) ER patients with acute chest pain that underwent initial “triple rule out” CT to evaluate for coronary artery disease (CAD), pulmonary embolus (PE) 
or acute aortic dissection (AAA).
2) ER patients with acute chest pain that underwent initial conventional CT angiogram to evaluate for PE or AAA and other non-CT test for CAD.
Studies performed to confirm a result were considered downstream examinations.
Results:  Between July-December 2009, 188 “triple rule out” CTA and 616 CTA chest and aorta studies were performed on patients presenting 
to the ED with ACP that had confounding clinical presentations for possible CAD, PE, or AAA. The mean effective dose was 13.7 mSv with a range of 
1.3 to 73.2 mSv for the “triple rule out” group. Patients in the traditional CTA group received a dose of 16.0 mSv with a range from 1.3 to 116.0 
mSv. Patients in the “triple rule out” group had a total of 12 additional studies with an additional dose of 174 mSv. In comparison, patients in the 
traditional CTA evaluation group had an additional 63 studies receiving a dose of 1013.8 mSv. There was a 43.8% decrease in radiation dose from 
downstream exams in the “triple rule out” group compared to the traditional CTA group.
Conclusions:  Our study demonstrated that in selected ED patients with ACP, not only does a “triple rule out” study confer a lower per study dose 
to the patient, the number of downstream studies were also reduced compared to the traditional CTA group.
